Close

Analyst Comments After Rockwell Medical (RMTI) PRIME Study Selected as Best Abstract

January 7, 2014 10:51 AM EST Send to a Friend
Summer Street Tuesday maintained a Buy rating on Rockwell Medical Technologies (NASDAQ: RMTI) with a price target of $25.00. Comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login